| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $20.00 | 02 Mar 2023 | Direct | |
| OPIANT PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 0 | $10.00 | 02 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000138550823000077-silver-gabrielle-alison-2023-03-02 | OPIANT PHARMACEUTICALS, INC. | 02 Mar 2023 | 6 | -$466,860 | 4 | Director | 03 Mar 2023, 08:27 |
| /report/000138550822000082-silver-gabrielle-alison-2022-06-14 | OPIANT PHARMACEUTICALS, INC. | 14 Jun 2022 | 1 | $0 | 4 | Director | 14 Jun 2022, 16:51 |
| /report/000138550822000062-silver-gabrielle-alison-2022-05-16 | OPIANT PHARMACEUTICALS, INC. | 16 May 2022 | 1 | +$33,220 | 4 | Director | 17 May 2022, 16:04 |
| /report/000138550821000085-silver-gabrielle-alison-2021-06-15 | OPIANT PHARMACEUTICALS, INC. | 15 Jun 2021 | 2 | $0 | 4 | Director | 16 Jun 2021, 16:05 |
| /report/000138550821000071-silver-gabrielle-alison-2021-05-13 | OPIANT PHARMACEUTICALS, INC. | 13 May 2021 | 2 | +$3,650 | 4 | Director | 13 May 2021, 16:10 |